LANXESS has announced the reappointment of Oliver Stratmann as Chief Financial Officer, with the Supervisory Board extending his contract by five years. The new term commences on September 1, 2026, directly following his initial three-year appointment.
The specialty chemicals company, which reported sales of EUR 6.4 billion in 2024, confirmed the extension reflects confidence in Stratmann’s financial leadership during a period of industry-wide challenges.
“Oliver Stratmann is doing an excellent job as Chief Financial Officer in these challenging times,” said Rainier van Roessel, Chairman of the Supervisory Board. He emphasized that solid financial planning and comprehensive knowledge of financial markets are particularly valuable in the current environment.
CEO Matthias Zachert expressed support for the decision, noting Stratmann’s expertise in navigating the crisis affecting the chemical industry sector.
LANXESS is a specialty chemicals company headquartered in Cologne, Germany, operating through three business segments: Advanced Industrial Intermediates, Specialty Additives, and Consumer Protection. The company employs approximately 11,800 people across 32 countries and maintains production facilities in multiple global regions.
LANXESS develops, manufactures, and markets chemical intermediates, additives, and consumer protection products serving various industrial applications and markets. The company operates nine business units and maintains a presence on sustainability indices including the Dow Jones Sustainability Index. LANXESS was established in 2004 following a spin-off from Bayer AG and has set a target to achieve carbon neutrality by 2040.